{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fmedicalspecialtiespodcast.simplecast.com%2Fepisodes%2Fresidual-risk-in-ascvd-and-ckd-E_mGCbAD","width":444,"version":"1.0","type":"rich","title":"Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/8ee90d58-c3df-45f9-9d86-483903fabf47/7678-pod1-residual-risk-in-ascvd-and-ckd-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/7943c5d7-2236-43af-8299-c69c2bb1a6df\" height=\"200\" width=\"100%\" title=\"Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Join us for this podcast episode with cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the relationship of residual risk associated with systemic inflammation in patients with ASCVD and CKD. "}